| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.3 | 0.06 |